Oppenheimer Downgrades Crinetics (CRNX) to Perform

July 7, 2026 3:33 AM

Oppenheimer analyst Leland Gershell downgraded Crinetics (NASDAQ: CRNX) from Outperform to Perform.The analyst comments: “VRTX (OP, Olson) will acquire CRNX ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found